PlainRecalls
FDA Drug Moderate Class II Terminated

Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90

Reported: August 3, 2022 Initiated: July 18, 2022 #D-1294-2022

Product Description

Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90

Reason for Recall

Failed Dissolution Specifications

Details

Units Affected
28,560 bottles
Distribution
Nationwide within the United States
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 28,560 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on August 3, 2022. Severity: Moderate. Recall number: D-1294-2022.